-
RNAseq samples of patients with anti-PD-1 resistant HNSCC from a non-randomized, open-label phase 1b clinical trial
Study
EGAS50000000728
-
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
Study
EGAS50000000714
-
Distinct immune cell infiltration patterns in PDAC exhibit divergent immune cell selection and immunosuppressive mechanisms
Study
EGAS50000000726
-
Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies
Study
EGAS50000000710
-
Epstein-Barr Virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review
Study
EGAS50000000706
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
MET amplification in gastric cancer
Study
EGAS50000000744
-
Integrated genetic and epigenetic analysis defines novel molecular clusters in rhabdomyosarcoma
Study
EGAS00001000884
-
The genetic footprint of the European Roma diaspora: Evidence from the Balkans to the Iberian Peninsula
Study
EGAS50000000746
-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Study
EGAS50000000757
-
Djerroudi et al., E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000000761
-
Analysis of T cells in follicular lymphoma
Study
EGAS50000000778
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_ATAC
Study
EGAS00001008083
-
Single cell RNA sequencing of CD19 CAR T-cell infusion products
Study
EGAS00001004576
-
Genomic Profiling of an anti-PD-L1 treated cohort of Newly Diagnosed GBM patients
Study
EGAS50000000783
-
Transcriptomic Profiling of an Anti-PD-L1 Treated Cohort of Newly Diagnosed GBM Patients
Study
EGAS50000000784
-
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
Study
EGAS00001003438
-
Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers
Study
EGAS00001003452
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000801
-
Genomic analysis of head and neck squamous cell carcinoma upon acquired resistance to cetuximab
Study
EGAS50000000800
-
Blood-based monitoring of relapsed/refractory cHL patients predict responses to PD-1 blockade treatment
Study
EGAS00001005894
-
Diagnostic Genomic Analysis is Prognostic in AYA ALL Patients Treated on a MRD-Stratified Paediatric Protocol
Study
EGAS50000000752
-
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
Study
EGAS50000000770
-
A Phase Ib/II Study of Regorafenib and Paclitaxel in Beyond First-line Advanced Esophagogastric Carcinoma (REPEAT)
Study
EGAS00001006054
-
Tumor-reactive heterotypic CD8 T cell clusters from clinical samples
Study
EGAS50000000785
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Novel Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000803
-
Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor
Study
EGAS50000000811
-
Integrative analysis reveals a macrophage-predominant, immunosuppressive immune microenvironment and subtype-specific therapeutic vulnerabilities in advanced salivary gland cancer
Study
EGAS50000000809
-
Whole Exome Sequencing of a Lung Adenocarcinoma Patient Across Three Time Points
Study
EGAS50000000812
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Neuroblastoma Cell Line Circle-seq
Study
EGAS00001004796
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal_LCM
Study
EGAS00001003455
-
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis
Study
EGAS50000000825
-
Tumor-resident T-cell regulate responses to checkpoint blockade immunotherapies
Study
EGAS50000000826
-
Molecular biomarkers for stratification periheral T cell lymphoma
Study
EGAS00001006691
-
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Study
EGAS00001000906
-
Genomic_landscape_of_liver_cirrhosis
Study
EGAS00001004329
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Study
EGAS00001004349
-
Whole Genome Sequencing of Neuroblastoma
Study
EGAS00001000222
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Study
EGAS00001001024
-
Inferring tumor genomes from peripheral blood i.e. CTCs and plasma-DNA using deep sequencing and targeted enrichment
Study
EGAS00001000337
-
Genetic_profiling_of_mucosal_melanoma
Study
EGAS00001001115
-
Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma
Study
EGAS00001003490
-
Whole-genome-Sequencing of adult medulloblastoma
Study
EGAS00001000393
-
Human melanoma samples with and without resistance to BRAF inhibitor therapy
Study
EGAS00001000992
-
ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000561
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Study
EGAS00001001002
-
Spatial heterogeneity in medulloblastoma
Study
EGAS00001001014
-
Exome and transcriptome sequencing of Desmoplastic Small Round Cell Sarcoma
Study
EGAS00001004575
-
Exploration of CNV’s and SNV’s in cancers with well-known genetic rearrangements: Identification of additional genetic changes in rearrangements-driven cancer
Study
EGAS00001000673
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
The genomic landscape of primary cutaneous anaplastic large cell lymphoma (pcALCL)
Study
EGAS00001004429
-
Neuroblastoma relapse trio series from the AMC
Study
EGAS00001001183
-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Comprehensive Transcriptional Analysis of Early Stage Urothelial Carcinoma using whole transcriptome sequencing
Study
EGAS00001001236
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Neuroblastoma Evolution
Study
EGAS00001006533
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Multiomic profiling of early-passage melanoma cell lines.
Study
EGAS00001004536
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Phylogenetic evolution of metastatic melanoma.
Study
EGAS00001003582
-
Carcinoma of the oral tongue (OTSCC) genomic landscape characterisation
Study
EGAS00001001329
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588